Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like Gene Expression, RNA Editing, and MicroRNAs Regulation

  • Wei CaoEmail author
  • Wei Wu
Part of the Methods in Molecular Biology book series (MIMB, volume 1699)


Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) protein family is encoded by eleven genes located in human genome. APOBECs are a family of evolutionarily conserved cytidine deaminases in vertebrates, and particularly in mammals. APOBECs play key roles in innate immunity against viral infection and retrotransposons. Subtypes of APOBEC3 can cause specific mutations in RNA and DNA at distinct preferred nucleotide contexts in human cancer. The pervasive APOBEC3s activation in the host genome converts cytosine to uracile on single-stranded DNA, which has been suggested to depend on ATR/chk1 pathways. In this chapter, we review the expression profiling of APOBEC expression in normal and disease states, discuss how microRNAs interact with APOBEC gene family, and post-transcriptionally regulate APOBEC gene expression in the APOBECA-B fusion allele and APOBEC-mediated RNA editing. It is reasonable to speculate targeting specific microRNAs may reduce host genome mutagenesis via inactivation of APOBEC deaminases.

Key words

MicroRNAs APOBEC Mutagenesis Mutation signature DND1 P-Bodies 



This work is supported by joint funding of natural science foundation of Henan province (grant #: 162300410279) and Henan science and technology research program (international collaborative project, 152102410088).


  1. 1.
    Refsland EW, Harris RS (2013) The APOBEC3 family of retroelement restriction factors. Curr Top Microbiol Immunol 371:1–27. Epub 2013/05/21PubMedPubMedCentralGoogle Scholar
  2. 2.
    Harris RS, Liddament MT (2004) Retroviral restriction by APOBEC proteins. Nat Rev Immunol 4(11):868–877. Epub 2004/11/02CrossRefPubMedGoogle Scholar
  3. 3.
    Burns MB, Temiz NA, Harris RS (2013) Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet 45(9):977–983. Epub 2013/07/16CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P et al (2013) An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet 45(9):970–976. Epub 2013/07/16CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kanu N, Cerone MA, Goh G, Zalmas LP, Bartkova J, Dietzen M et al (2016) DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer. Genome Biol 17(1):185. Epub 2016/09/17CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Wu W, Sun M, Zou GM, Chen J (2007) MicroRNA and cancer: current status and prospective. Int J Cancer 120(5):953–960CrossRefPubMedGoogle Scholar
  7. 7.
    Sevignani C, Calin GA, Siracusa LD, Croce CM (2006) Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome 17(3):189–202CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R (2005) MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7(7):719–723. Epub 2005/06/07CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO et al (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274(26):18470–18476. Epub 1999/06/22CrossRefPubMedGoogle Scholar
  10. 10.
    Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T et al (2007) Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 13(4):470–476. Epub 2007/04/03CrossRefPubMedGoogle Scholar
  11. 11.
    Robbiani DF, Nussenzweig MC (2013) Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase. Annu Rev Pathol 8:79–103. Epub 2012/09/15CrossRefPubMedGoogle Scholar
  12. 12.
    Navaratnam N, Morrison JR, Bhattacharya S, Patel D, Funahashi T, Giannoni F et al (1993) The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J Biol Chem 268(28):20709–20712. Epub 1993/10/05PubMedGoogle Scholar
  13. 13.
    Teng B, Burant CF, Davidson NO (1993) Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260(5115):1816–1819. Epub 1993/06/18CrossRefPubMedGoogle Scholar
  14. 14.
    Yamanaka S, Balestra ME, Ferrell LD, Fan J, Arnold KS, Taylor S et al (1995) Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A 92(18):8483–8487. Epub 1995/08/29CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, Scott J et al (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79(3):285–296. Epub 2002/02/28CrossRefPubMedGoogle Scholar
  16. 16.
    Rogozin IB, Basu MK, Jordan IK, Pavlov YI, Koonin EV (2005) APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis. Cell Cycle 4(9):1281–1285. Epub 2005/08/06CrossRefPubMedGoogle Scholar
  17. 17.
    Conticello SG (2008) The AID/APOBEC family of nucleic acid mutators. Genome Biol 9(6):229. Epub 2008/07/05CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Kidd JM, Newman TL, Tuzun E, Kaul R, Eichler EE (2007) Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet 3(4):e63. Epub 2007/04/24CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Nik-Zainal S, Wedge DC, Alexandrov LB, Petljak M, Butler AP, Bolli N et al (2014) Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. Nat Genet 46(5):487–491. Epub 2014/04/15CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Caval V, Suspene R, Shapira M, Vartanian JP, Wain-Hobson S (2014) A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage. Nat Commun 5:5129. Epub 2014/10/10CrossRefPubMedGoogle Scholar
  21. 21.
    Henderson S, Fenton T (2015) APOBEC3 genes: retroviral restriction factors to cancer drivers. Trends Mol Med 21(5):274–284. Epub 2015/03/31CrossRefPubMedGoogle Scholar
  22. 22.
    Huang J, Liang Z, Yang B, Tian H, Ma J, Zhang H (2007) Derepression of microRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members. J Biol Chem 282(46):33632–33640. Epub 2007/09/13CrossRefPubMedGoogle Scholar
  23. 23.
    Ali S, Karki N, Bhattacharya C, Zhu R, MacDuff DA, Stenglein MD et al (2013) APOBEC3 inhibits DEAD-END function to regulate microRNA activity. BMC Mol Biol 14:16. Epub 2013/07/31CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Kaul D, Arora M, Garg A, Sharma S (2015) MALT1 induced immune response is governed by miR-2909 RNomics. Mol Immunol 64(1):210–217. Epub 2014/12/17CrossRefPubMedGoogle Scholar
  25. 25.
    Blanc V, Davidson NO (2003) C-to-U RNA editing: mechanisms leading to genetic diversity. J Biol Chem 278(3):1395–1398. Epub 2002/11/26CrossRefPubMedGoogle Scholar
  26. 26.
    Mukhopadhyay D, Anant S, Lee RM, Kennedy S, Viskochil D, Davidson NO (2002) C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme. Am J Hum Genet 70(1):38–50. Epub 2001/12/01CrossRefPubMedGoogle Scholar
  27. 27.
    Anant S, Davidson NO (2000) An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3′ untranslated region of c-myc increases mRNA stability. Mol Cell Biol 20(6):1982–1992. Epub 2000/02/25CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Blanc V, Park E, Schaefer S, Miller M, Lin Y, Kennedy S et al (2014) Genome-wide identification and functional analysis of Apobec-1-mediated C-to-U RNA editing in mouse small intestine and liver. Genome Biol 15(6):R79. Epub 2014/06/21CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2018

Authors and Affiliations

  1. 1.Translational Medical CenterZhengzhou Central Hospital, Affiliated to Zhengzhou UniversityZhengzhouPeople’s Republic of China
  2. 2.Department of Medicine, Helen Diller Family Comprehensive Cancer CenterUniversity of California in San FranciscoSan FranciscoUSA

Personalised recommendations